[HTML][HTML] Role of succinylation modification in thyroid cancer and breast cancer

R Mu, Z Ma, C Lu, H Wang, X Cheng… - American Journal of …, 2021 - ncbi.nlm.nih.gov
The incidence of thyroid cancer and breast cancer is increasing year by year, and the
specific pathogenesis is unclear. Posttranslational modifications constitute an important …

[HTML][HTML] Targeting succinylation-mediated metabolic reprogramming as a potential approach for cancer therapy

Z Liu, R Wang, Y Wang, Y Duan, H Zhan - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Metabolic reprogramming is a common hallmark of cancers and involves alterations in many
metabolic pathways during tumor initiation and progression. However, the cancer-specific …

Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production

DB Allison, J Rueckert, V Cornea, CY Lee, J Dueber… - Endocrine …, 2022 - Springer
In this report, we present a high-grade thyroid carcinoma with an NSD3:: NUTM1 fusion
detected on expanded next-generation sequencing testing. Nuclear protein of the testis …

Identification of a mitochondria-related gene signature to predict the prognosis in AML

N Jiang, X Zhang, Q Chen, F Kantawong, S Wan… - Frontiers in …, 2022 - frontiersin.org
Mitochondria-related metabolic reprogramming plays a major role in the occurrence,
development, drug resistance, and recurrence of acute myeloid leukemia (AML). However …

Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity

L Zhang, M Zhou, X Gao, Y Xie, J Xiao, T Liu, X Zeng - BMC cancer, 2023 - Springer
Background Thyroid cancer (THCA) has become increasingly common in recent decades,
and women are three to four times more likely to develop it than men. Evidence shows that …

A glimpse into novel acylations and their emerging role in regulating cancer metastasis

H Shi, W Cui, Y Qin, L Chen, T Yu, J Lv - Cellular and Molecular Life …, 2024 - Springer
Metastatic cancer is a major cause of cancer-related mortality; however, the complex
regulation process remains to be further elucidated. A large amount of preliminary …

Posttranslational modifications in thyroid cancer: implications for pathogenesis, diagnosis, classification, and treatment

JM Broekhuis, BC James, RD Cummings… - Cancers, 2022 - mdpi.com
Simple Summary Alterations to human proteins following their production can result in
changes to their function. In cancers specifically, these post-translational modifications …

Proteomics in thyroid cancer and other thyroid-related diseases: A review of the literature

Y Ucal, A Ozpinar - Biochimica et Biophysica Acta (BBA)-Proteins and …, 2020 - Elsevier
Misdiagnosis, over-diagnosis, or inappropriate treatment strategies are frequently seen in
thyroid disease management. Currently, there is an urgent interest to identify biomarkers for …

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer

A Valdés, A Bitzios, E Kassa, G Shevchenko, A Falk… - Scientific Reports, 2021 - nature.com
Samples in biobanks are generally preserved by formalin-fixation and paraffin-embedding
(FFPE) and/or optimal cutting temperature compound (OCT)-embedding and subsequently …

Proteotypic differences of follicular-patterned thyroid neoplasms

D Huang, H Zhang, L Li, W Ge, W Liu, Z Dong… - Frontiers in …, 2022 - frontiersin.org
The diagnosis of follicular-patterned thyroid tumors such as follicular thyroid adenoma (FA),
follicular thyroid carcinoma (FTC), and follicular variant of papillary thyroid carcinoma …